WINDTREE THERAPEUTICS INC /DE/ Proceeds from Notes Payable
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Proceeds from Notes Payable of $500.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ proceeds from notes payable for the quarter ending 2025-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from notes payable for the quarter ending 2024-09-30 was -$350.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $500.00K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-19 | ||
| 2024-09-30 | -$350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $0.00 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $350.00K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |